MAP2K1 and esophageal squamous cell carcinoma: The PI3K inhibitor LY294002 and MEK1/2 inhibitor PD98059 suppressed the induction of both migration and invasion in rhPAI-1-treated ESCC cells (Fig. 3f, g).